| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016863A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/08/1999 | WO1999016790A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
| 04/08/1999 | WO1999016787A1 Cell death agonists |
| 04/08/1999 | WO1999016783A1 Potent inhibitors of human 9-cis retinol dehydrogenase |
| 04/08/1999 | WO1999016473A1 Lipid a 4' kinase |
| 04/08/1999 | WO1999016458A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999009161A8 Pancreas-derived plasminogen activator inhibitor |
| 04/08/1999 | WO1999006549A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 04/08/1999 | WO1999006439A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/08/1999 | WO1999005269A3 Transcriptional silencer protein nrf |
| 04/08/1999 | WO1999004026A3 Lentiviral vectors |
| 04/08/1999 | WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1998057664A9 Interleukin converting enzyme (ice) and central nervous system damage |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | WO1998049321A8 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 04/08/1999 | CA2305809A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
| 04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | CA2305686A1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304007A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/08/1999 | CA2303401A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | CA2290809A1 Lipid a 4' kinase |
| 04/08/1999 | CA2246626A1 Rabies recombinant adenovirus |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth) |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906444A1 Genetically transfected human dendritic cells, their production and use, preferably as vaccines |
| 04/07/1999 | EP0906443A1 Generating replicating molecules in vivo |
| 04/07/1999 | EP0906442A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906439A1 Polycistronic expression plasmid for tumor-rejection |
| 04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906124A2 Device and method for encapsulated gene therapy |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906116A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells |
| 04/07/1999 | EP0906110A1 Dna vaccine formulations |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | CN1213004A Recombination leukocyte mesonium-2 adenovirus carrier and producing method |
| 04/07/1999 | CN1212890A Compositions useful for transferring therapeutically active substances into target cell, and their use in gene therapy |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892071 Cationic transport reagents |
| 04/06/1999 | US5891857 Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
| 04/06/1999 | US5891718 Positive feedback antibiotic controlled eukaryotic expression vectors with single transcription unit of first cistron coding for gene product, second cistron coding for antibiotic controlled activator; gene therapy and gene immunization |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891689 Heme-bearing microparticles for targeted delivery of drugs |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891667 SpoIIIe polynucleotides |
| 04/06/1999 | US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies. |
| 04/06/1999 | US5891475 Non-liquid hydrophilic core, an external layer comprised of lipid compounds grafted on the core by covalent bonds. enhancing the activity of the polypeptide cellular mediator. |
| 04/06/1999 | US5891468 Fusogenic liposome compositions and method |
| 04/06/1999 | US5891459 Arginine, lysine and salts with nutrients for nitric oxide intermediates |
| 04/06/1999 | US5891432 Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015687A1 Multicomponent polynucleotide complex for high efficiency cell transfection |
| 04/01/1999 | WO1999015685A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015683A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | WO1999015677A1 Method for gene transfer using bcl2 and compositions useful therein |
| 04/01/1999 | WO1999015671A1 Hepatitis b virus polypeptides |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015655A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 04/01/1999 | WO1999015650A1 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| 04/01/1999 | WO1999015649A2 Composition and method for enhancing paracellular transport across cell layers |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015630A1 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy |
| 04/01/1999 | WO1999015626A1 Identification of hop-1 and uses thereof |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015544A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE brx GENE AND GENE PRODUCT, AND USES THEREOF |
| 04/01/1999 | WO1999015206A1 Methods for preparing lipids/polynucleotide transfection complexes |
| 04/01/1999 | WO1999015199A1 Antigen presenting mesenchymal stem cells |
| 04/01/1999 | WO1999015190A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1999001551A3 Novel inhibitor of cellular proliferation |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | WO1998055611A9 Neuregulin response element and uses therefor |
| 04/01/1999 | WO1998054313A3 Dna methyltransferase genomic sequences and antisense oligonucleotides |
| 04/01/1999 | WO1998054301A3 Transplants for myocardial scars and method and cellular preparations therefor |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | WO1998052615A9 Controlling immune response to specific antigens |
| 04/01/1999 | WO1998052581A9 Vectors and methods for immunization or therapeutic protocols |